Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status.

Lancet (London, England) - 27 Apr 2002

Haffty Bruce G, Harrold Elizabeth, Khan Atif J, Pathare Pradip, Smith Tanya E, Turner Bruce C, Glazer Peter M, Ward Barbara, Carter Daryl, Matloff Ellen, Bale Allen E, Alvarez-Franco Mayra

Abstract excerpt

BACKGROUND: Management of early-stage breast cancer in young women with mutations in BRCA1 or BRCA2 remains controversial. This study assessed the long-term risks of ipsilateral and contralateral breast cancer in a cohort of young women who underwent breast-conserving surgery followed by radiotherapy. METHODS: Between 1975 and 1998, 290 women with breast cancer diagnosed at age 42 years or younger underwent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 Protein

Share to Combined Modality Therapy

Share to Disease-Free Survival

Share to DNA, Neoplasm

Share to Neoplasm Recurrence, Local

Share to Radiotherapy

Source

Identifiers

PMID: 11988246
DOI: 10.1016/S0140-6736(02)08434-9

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status.PMID 11988246Read ↗

Conservative management of breast cancer in BRCA1/2 mutation carriers.Semantic proximity Read ↗

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.Semantic proximity Read ↗

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study.Semantic proximity Read ↗

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.Semantic proximity Read ↗

Breast cancer in women at high risk: the role of rapid genetic testing for BRCA1 and -2 mutations and the consequences for treatment strategies.Semantic proximity Read ↗

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.Semantic proximity Read ↗

Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review.Semantic proximity Read ↗

High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.Semantic proximity Read ↗

Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis.Semantic proximity Read ↗

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Radiotherapy for breast cancer in BRCA1/BRCA2 carriers: clinical issues and management dilemmas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.